Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology

[1]  B. Strom,et al.  Reproductive factors and risk of breast carcinoma in a study of white and African‐American women , 2004, Cancer.

[2]  David Botstein,et al.  Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. , 2004, Molecular biology of the cell.

[3]  M. Cotterchio,et al.  Hormonal factors and the risk of breast cancer according to estrogen- and progesterone-receptor subgroup. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  P. Porter,et al.  Relationship between long durations and different regimens of hormone therapy and risk of breast cancer. , 2003, JAMA.

[5]  P. Wingo,et al.  Relation of regimens of combined hormone replacement therapy to lobular, ductal, and other histologic types of breast carcinoma , 2002, Cancer.

[6]  M. García-Closas,et al.  Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre‐menopausal women , 2002, International journal of cancer.

[7]  D. Brogan,et al.  Risk of breast cancer classified by joint estrogen receptor and progesterone receptor status among women 20-44 years of age. , 2002, American journal of epidemiology.

[8]  J. Ranstam,et al.  Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease , 2002, The Lancet.

[9]  W. Anderson,et al.  Rates for Breast Cancer Characteristics by Estrogen and Progesterone Receptor Status in the Major Racial/Ethnic Groups , 2002, Breast Cancer Research and Treatment.

[10]  P. Wingo,et al.  The NICHD Women's Contraceptive and Reproductive Experiences Study: methods and operational results. , 2002, Annals of epidemiology.

[11]  M. Pike,et al.  Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer? , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  L. Bernstein,et al.  Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  J. Stanford,et al.  Hormone replacement therapy in relation to risk of lobular and ductal breast carcinoma in middle‐aged women , 2000, Cancer.

[14]  R C Millikan,et al.  Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. , 2000, American journal of epidemiology.

[15]  K. Yoo,et al.  Breast cancer risk factors according to combined estrogen and progesterone receptor status: a case-control analysis. , 1997, American journal of epidemiology.

[16]  J. Cerhan,et al.  Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many kinds of breast cancer are there? , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[17]  P. Taylor,et al.  Relationships of age and reproductive characteristics with plasma estrogens and androgens in premenopausal women. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  J. Russo,et al.  Toward a physiological approach to breast cancer prevention. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  T. Murrell Epidemiological and biochemical support for a theory on the cause and prevention of breast cancer. , 1991, Medical hypotheses.

[20]  D. Horsfall,et al.  Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study. , 1989, British Journal of Cancer.

[21]  K. Horwitz The central role of progesterone receptors and progestational agents in the management and treatment of breast cancer. , 1988, Seminars in oncology.

[22]  V. Ernster,et al.  Influence of pregnancy and lactation on serum and breast fluid estrogen levels: Implications for breast cancer risk , 1987, International journal of cancer.

[23]  R. Hoover,et al.  A case-control study of breast cancer stratified by estrogen receptor status. , 1987, American journal of epidemiology.

[24]  D. Thomas,et al.  Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers. , 1986, Journal of the National Cancer Institute.

[25]  M. Pike,et al.  Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. , 1985, Journal of the National Cancer Institute.

[26]  J. Kelsey,et al.  Differences in breast cancer risk factors according to the estrogen receptor level of the tumor. , 1983, Journal of the National Cancer Institute.

[27]  J. Russo,et al.  Influence of age and parity on the development of the human breast , 2005, Breast Cancer Research and Treatment.

[28]  J L Kelsey,et al.  Reproductive factors and breast cancer. , 1993, Epidemiologic reviews.

[29]  N. Breslow,et al.  Statistical methods in cancer research: volume 1- The analysis of case-control studies , 1980 .